Epitomee Medical Ltd Asset Resilience Ratio
Epitomee Medical Ltd asset resilience ratio. Epitomee Medical Ltd (EPIT) has an Asset Resilience Ratio of 0.24% as of June 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read total liabilities of Epitomee Medical Ltd for a breakdown of total debt and financial obligations.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio of Epitomee Medical Ltd (2022–2024)
Asset resilience ratio of Epitomee Medical Ltd from 2022 to 2024. This chart shows how Epitomee Medical Ltd's Asset Resilience Ratio has changed over time. See Epitomee Medical Ltd (EPIT) free cash flow to measure how efficiently the company converts operating cash flow to free cash.
Liquid Assets Composition Over Time
This chart breaks down Epitomee Medical Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see EPIT asset base.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | ILA0.00 | 0% |
| Short-term Investments | ILA87.57K | 0.24% |
| Total Liquid Assets | ILA87.57K | 0.24% |
Asset Resilience Insights
- Limited Liquidity: Epitomee Medical Ltd maintains only 0.24% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
Epitomee Medical Ltd Industry Peers by Asset Resilience Ratio
Compare Epitomee Medical Ltd's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Shenzhen New Industries Biomedical
SHE:300832 |
Medical Devices | 9.95% |
|
GN Store Nord
CO:GN |
Medical Devices | -4.56% |
|
Shanghai Aohua Photoelectricity Endoscope Co. Ltd. A
SHG:688212 |
Medical Devices | 6.09% |
|
Polynovo Ltd
AU:PNV |
Medical Devices | 0.04% |
|
L&C Bio Co. Ltd
KQ:290650 |
Medical Devices | 2.14% |
|
VIROMED MEDICAL NA O.N.
XETRA:VME |
Medical Devices | 0.03% |
|
Affluent Medical SAS
PA:AFME |
Medical Devices | 0.03% |
|
DRGEM Corporation
KQ:263690 |
Medical Devices | 2.12% |
Epitomee Medical Ltd Asset Resilience Ratio by Year (2022–2024)
Epitomee Medical Ltd asset resilience ratio by year from 2022 to 2024. The table below shows the annual Asset Resilience Ratio data for Epitomee Medical Ltd.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2024-12-31 | 49.84% | ILA20.04 Million ≈ $53.73K |
ILA40.21 Million ≈ $107.81K |
-14.97pp |
| 2022-12-31 | 64.81% | ILA35.78 Million ≈ $95.92K |
ILA55.20 Million ≈ $147.99K |
-- |
About Epitomee Medical Ltd
Epitomee Medical Ltd, a biomedical company, develops and commercializes ingestible therapeutic devices worldwide. It offers capsules, which are polymer-based scaffold for controlled delivery of therapies along the GI tract for weight management and biologics delivery. The company was incorporated in 2005 and is based in Caesarea, Israel.